Genome Therapeutics Corp., which specializes in identifying genes to help develop new drugs, said Thursday it signed a collaboration agreement valued at 97.6 million with Schering plough Corp. to discover new agents for use against drug resistant organisms.
Genome Schering to seek ways to fight drug resistant organisms.